Anson Medical gears up distribution network:
This article was originally published in Clinica
Executive Summary
Lombard Medical subsidiary Anson Medical has formed distribution agreements in Italy, Ireland and South Africa for its Aorfix device for the endovascular treatment of abdominal aortic aneurysms (AAA). The deals are with Seda of Milan, Italy, Unitech of Dublin, and Viking Medical and Scientific of Edenglen (South Africa). Anson's CEO Dr Peter Philips said the company is assessing a number of other distribution possibilities and plans to have the majority of its worldwide distribution network established over the next few months.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.